Washed microbiota transplant for C. diff infection
Part of Infections clinical trials.
This trial tests a treatment called washed microbiota transplantation (WMT) for people with a C. diff infection that causes diarrhea. WMT uses processed donor bacteria to help restore healthy gut balance and fight the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed C. diff infection (positive lab test or pseudomembranous colitis on colonoscopy) and have diarrhea (≥3 loose stools per day for at least 2 days).
- You are not pregnant or breastfeeding, and are willing to use effective birth control for 3 months after treatment.
- You do not have a weak immune system (e.g., HIV, low white blood cells) or take high-dose steroids or other immune-suppressing drugs.
- You have no severe bowel blockage or narrowing, and have not had major abdominal surgery (except gallbladder or appendix removal) in the past 6 months.
- You do not have another active infection besides C. diff.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental treatment called CMTS0929 for people with a C. difficile infection that is causing diarrhea. The treatment is given through a tube placed through the nostril or mouth into the intestine, and the study will see if it is safe and helpful.
This trial tests whether giving a stool transplant (also called FMT) can treat a new, early C. difficile infection in people who have improved while on antibiotics. It may help some people prevent the infection from coming back or worsening.
This study tests a freeze-dried fecal microbiota transplant (FMT) to see if it helps with diarrhea-predominant irritable bowel syndrome (IBS-D) or prevents repeat C. diff infections. FMT introduces healthy bacteria into your gut to restore balance.
This trial compares three treatments for a severe diarrhea infection called C. diff: a fecal transplant (putting healthy donor stool into your gut), a newer antibiotic called fidaxomicin, and an older antibiotic called vancomycin. The goal is to see which works best and prevents the infection from coming back.
This study is looking at people who were treated for C. diff (a serious gut infection) at Umeå University Hospital to see how they are doing years later. It compares people who got a fecal transplant (a treatment that restores healthy gut bacteria) with those who only took antibiotics.
This study tests whether taking a capsule form of fecal microbiota transplant (FMT) can help adults with their first C. difficile infection—or a first relapse—get better and reduce repeat episodes. Participants also take specific antibiotics for C. difficile as part of the study process.
Hear when a new Clostridioides Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.